<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35394215</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>18</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>18</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1432-0878</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>388</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Cell and tissue research</Title>
          <ISOAbbreviation>Cell Tissue Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Regulation of inflammation by VEGF/BDNF signaling in mouse retinal Müller glial cells exposed to high glucose.</ArticleTitle>
        <Pagination>
          <StartPage>521</StartPage>
          <EndPage>533</EndPage>
          <MedlinePgn>521-533</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00441-022-03622-z</ELocationID>
        <Abstract>
          <AbstractText>The inflammatory changes seem to play an important role in the development of diabetic retinopathy (DR). Anti-VEGF therapy has been testified to inhibit inflammation in animal models of diabetes, but the detailed mechanisms during this process are not yet clear. Müller glial cells (MGCs) in the mammalian retina are deeply involved in DR, while the BDNF overexpression reduces inflammation in diabetic mice. In this research, we aimed to explore the relationship between VEGF and BDNF in mouse retinal MGCs during inflammation of diabetes. We examined the expression of glutamine-synthetase (GS), glial fibrillary acidic protein (GFAP), vascular-endothelial growth factor (VEGF), interleukin-1beta (IL-1β), and tumor necrosis factor-alpha (TNF-α) at different time points after mouse retinal MGCs exposed to high glucose (25 mM). We also explored changes in the expression of brain-derived neurotrophic factor (BDNF), nuclear factor kappa B (NF-κB), IL-1β, and TNF-α in MGCs after treatments with anti-VEGF, VEGF siRNA, BDNF siRNA, BDNF recombination protein, and NF-κB inhibitor. In mouse retinal MGCs exposed to high glucose, BDNF was increased after treatments with anti-VEGF or VEGF siRNA. BDNF was decreased in MGCs from VEGF overexpressed mice. Moreover, the expressions of NF-κB, IL-1β, and TNF-α changed with BDNF: NF-κB, IL-1β, and TNF-α were increased after treatments with BDNF siRNA; NF-κB, IL-1β, and TNF-α were decreased after treatments with BDNF recombination protein. VEGF may regulate cytokines (IL-1β and TNF-α) by BDNF/NF-κB signaling pathway. The regulation of the VEGF/BDNF/NF-κB signaling pathway may be a significant therapeutic strategy for DR.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y" EqualContrib="Y">
            <LastName>Zhu</LastName>
            <ForeName>Minqi</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology, Shanghai Jiao Tong University Medical School Affiliated Ruijin Hospital, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y" EqualContrib="Y">
            <LastName>Li</LastName>
            <ForeName>Na</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology, Shanghai Jiao Tong University Medical School Affiliated Ruijin Hospital, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Yanuo</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology, Shanghai Jiao Tong University Medical School Affiliated Ruijin Hospital, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gao</LastName>
            <ForeName>Shuang</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology, Shanghai Jiao Tong University Medical School Affiliated Ruijin Hospital, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Jing</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology, Shanghai Jiao Tong University Medical School Affiliated Ruijin Hospital, Shanghai, China. kingrystal@163.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shen</LastName>
            <ForeName>Xi</ForeName>
            <Initials>X</Initials>
            <Identifier Source="ORCID">0000-0001-9669-6521</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology, Shanghai Jiao Tong University Medical School Affiliated Ruijin Hospital, Shanghai, China. carl_shen2005@126.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>08</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Cell Tissue Res</MedlineTA>
        <NlmUniqueID>0417625</NlmUniqueID>
        <ISSNLinking>0302-766X</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D019208">Brain-Derived Neurotrophic Factor</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D034741">RNA, Small Interfering</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D042461">Vascular Endothelial Growth Factor A</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>IY9XDZ35W2</RegistryNumber>
          <NameOfSubstance UI="D005947">Glucose</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019208" MajorTopicYN="N">Brain-Derived Neurotrophic Factor</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003921" MajorTopicYN="Y">Diabetes Mellitus, Experimental</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003930" MajorTopicYN="Y">Diabetic Retinopathy</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D063928" MajorTopicYN="N">Ependymoglial Cells</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005947" MajorTopicYN="N">Glucose</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008322" MajorTopicYN="N">Mammals</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D034741" MajorTopicYN="N">RNA, Small Interfering</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D042461" MajorTopicYN="N">Vascular Endothelial Growth Factor A</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Brain-derived neurotrophic factor</Keyword>
        <Keyword MajorTopicYN="N">Diabetic retinopathy</Keyword>
        <Keyword MajorTopicYN="N">High glucose</Keyword>
        <Keyword MajorTopicYN="N">Müller glial cells</Keyword>
        <Keyword MajorTopicYN="N">Vascular endothelial growth factor</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>9</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>8</Day>
          <Hour>12</Hour>
          <Minute>4</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35394215</ArticleId>
        <ArticleId IdType="doi">10.1007/s00441-022-03622-z</ArticleId>
        <ArticleId IdType="pii">10.1007/s00441-022-03622-z</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Adamis AP, Berman AJ (2008) Immunological mechanisms in the pathogenesis of diabetic retinopathy. Semin Immunopathol 30:65–84</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18340447</ArticleId>
            <ArticleId IdType="doi">10.1007/s00281-008-0111-x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Adamis AP, Miller JW, Bernal MT, D’Amico DJ, Folkman J, Yeo TK, Yeo KT (1994) Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 118:445–450</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7943121</ArticleId>
            <ArticleId IdType="doi">10.1016/S0002-9394(14)75794-0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Aiello LM, Ferrara N, King GL (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480–1487</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7526212</ArticleId>
            <ArticleId IdType="doi">10.1056/NEJM199412013312203</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Akkoyun I, Karabay G, Haberal N, Dagdeviren A, Yilmaz G, Oto S, Erkanli L, Akova YA (2012) Structural consequences after intravitreal bevacizumab injection without increasing apoptotic cell death in a retinopathy of prematurity mouse model. Acta Ophthalmol 90:564–570</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20698831</ArticleId>
            <ArticleId IdType="doi">10.1111/j.1755-3768.2010.01963.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Apte RS, Chen DS, Ferrara N (2019) VEGF in signaling and disease: beyond discovery and development. Cell 176(6):1248–1264</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30849371</ArticleId>
            <ArticleId IdType="pmc">6410740</ArticleId>
            <ArticleId IdType="doi">10.1016/j.cell.2019.01.021</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Behl T, Kotwani A (2017) Downregulated brain-derived neurotrophic factor-induced oxidative stress in the pathophysiology of diabetic retinopathy. Can J Diabetes 41:241–246</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27913110</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jcjd.2016.08.228</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bergami M, Teng HK, Zaitsev E, Woo NT, Sakata K, Zhen S, Teng KK, Yung WH, Hempstead BL, Lu B (2004) Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science 306(5695):487–491</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1100135</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bergami M, Vignoli B, Motori E, Pifferi S, Zuccaro E, Menini A, Canossa M (2013) TrkB signaling directs the incorporation of newly generated periglomerular cells in the adult olfactory bulb. J Neurosci 33(28):11464–11478</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23843518</ArticleId>
            <ArticleId IdType="pmc">6618681</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.4812-12.2013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Borges NB, Ferraz MB, Chacra AR (2014) The cost of type 2 diabetes in Brazil: evaluation of a diabetes care center in the city of Sao Paulo. Brazil Diabetol Metab Syndr 6(1):122</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25400703</ArticleId>
            <ArticleId IdType="doi">10.1186/1758-5996-6-122</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boss JD, Singh PK, Pandya HK, Tosi J, Kim C, Tewari A, Juzych MS, Abrams GW, Kumar A (2017) Assessment of neurotrophins and inflammatory mediators in vitreous of patients with diabetic retinopathy. Investig Ophthalmol vis Sci 58:5594–5603</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1167/iovs.17-21973</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Caviedes A, Lafourcade C, Soto C, Wyneken U (2017) BDNF/NF-κB signaling in the neurobiology of depression. Curr Pharm Des 23:3154–3163</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28078988</ArticleId>
            <ArticleId IdType="doi">10.2174/1381612823666170111141915</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chao CC, Ma YL, Lee EHY (2011) Brain-derived neurotrophic factor enhances Bcl-xL expression through protein kinase casein kinase 2-activated and nuclear factor kappa B-mediated pathway in rat hippocampus. Brain Pathol 21:150–162</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20731656</ArticleId>
            <ArticleId IdType="pmc">8094249</ArticleId>
            <ArticleId IdType="doi">10.1111/j.1750-3639.2010.00431.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coughlin BA, Guha-Niyogi P, Sikorskii A, Glazer LC, Mohr S (2020) Ranibizumab alters levels of intraocular soluble cytokine receptors in patients with diabetic macular edema. Curr Eye Res 45:4509–4520</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/02713683.2019.1665187</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Devi TS, Yumnamcha T, Yao F, Somayajulu M, Kowluru RA, Singh LP (2019) TXNIP mediates high glucose-induced mitophagic flux and lysosome enlargement in human retinal pigment epithelial cells. Biol Open 8(4):bio038521</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31023645</ArticleId>
            <ArticleId IdType="pmc">6503994</ArticleId>
            <ArticleId IdType="doi">10.1242/bio.038521</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, Zaitsev E, Gold B, Goldman D, Dean M, Bai Lu, Weinberger DR (2003) The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112:257–269</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12553913</ArticleId>
            <ArticleId IdType="doi">10.1016/S0092-8674(03)00035-7</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>El-Asrar AMA, Dralands L, Missotten L, Al-Jadaan IA, Geboes K (2004) Expression of apoptosis markers in the retinas of human subjects with diabetes. Investig Ophthalmol vis Sci 45:2760–2766</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1167/iovs.03-1392</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferrara N, Adamis AP (2016) Ten years of anti-vascular endothelial growth factor therapy. Nat Rev Drug Discov 15(6):385–403</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26775688</ArticleId>
            <ArticleId IdType="doi">10.1038/nrd.2015.17</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gnanasekaran S, Bandala-Sanchez E, Kolic M, Churilov L, Rogers SL, McAuley AK, Sandhu SS, Qureshi S, Lim LL, Wickremasinghe SS (2020) The association between intravitreal ranibizumab therapy and serum cytokine concentrations in patients with diabetic macular edema. Mol vis 26:246–256</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32256028</ArticleId>
            <ArticleId IdType="pmc">7127926</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hamanoue M, Middleton G, Wyatt S, Jaffray E, Hay RT, Davies AM (1999) p75-Mediated NF-kappaB activation enhances the survival response of developing sensory neurons to nerve growth factor. Mol Cell Neurosci 14:28–40</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10433815</ArticleId>
            <ArticleId IdType="doi">10.1006/mcne.1999.0770</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Han R, Liu Z, Sun N, Liu S, Li L, Shen Y, Xiu J, Xu Q (2019) BDNF alleviates neuroinflammation in the hippocampus of type 1 diabetic mice via blocking the aberrant HMGB1/RAGE/NF-κB pathway. Aging Dis 10:611–625</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31165005</ArticleId>
            <ArticleId IdType="pmc">6538223</ArticleId>
            <ArticleId IdType="doi">10.14336/AD.2018.0707</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hicks D, Courtois Y (1990) The growth and behavior of rat retinal Muller cells in vitro. 1. An improved method for isolation and culture. Exp Eye Res 51:119–129</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2387332</ArticleId>
            <ArticleId IdType="doi">10.1016/0014-4835(90)90063-Z</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Joussen AM, Murata T, Tsujikawa A, Kirchhof B, Bursell SE, Adamis AP (2001) Leukocyte-mediated endothelial cell injury and death in the diabetic retina. Am J Pathol 158:147–152</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11141487</ArticleId>
            <ArticleId IdType="pmc">1850259</ArticleId>
            <ArticleId IdType="doi">10.1016/S0002-9440(10)63952-1</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kern TS (2007) Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Res 2007:95103</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18274606</ArticleId>
            <ArticleId IdType="pmc">2216058</ArticleId>
            <ArticleId IdType="doi">10.1155/2007/95103</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kobrin Klein BE (2007) Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol 14:179–183</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/09286580701396720</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koleva-Georgieva DN, Sivkova NP, Terzieva D (2011) Serum inflammatory cytokines IL-1beta, IL-6, TNF-alpha and VEGF have influence on the development of diabetic retinopathy. Folia Med 53:44–50</Citation>
        </Reference>
        <Reference>
          <Citation>Kruger NJ (1994) The Bradford method for protein quantitation. Methods Mol Biol 32:9–15</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7951753</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kurihara T, Westenskow PD, Bravo S, Aguilar E, Friedlander M (2012) Targeted deletion of VEGF-A in adult mice induces vision loss. J Clin Investig 122:4213–4217</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23093773</ArticleId>
            <ArticleId IdType="pmc">3484459</ArticleId>
            <ArticleId IdType="doi">10.1172/JCI65157</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Le Y-Z (2017) VEGF production and signaling in Müller glia are critical to modulating vascular function and neuronal integrity in diabetic retinopathy and hypoxic retinal vascular diseases. Vision Res 139:108–114</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28601428</ArticleId>
            <ArticleId IdType="pmc">5723217</ArticleId>
            <ArticleId IdType="doi">10.1016/j.visres.2017.05.005</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Long H, Ruan J, Zhang M, Wang C, Huang Y (2019) Rhynchophylline attenuates Tourette syndrome via BDNF/NF-κB pathway in vivo and in vitro. Neurotox Res 36(4):756–763</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31243645</ArticleId>
            <ArticleId IdType="doi">10.1007/s12640-019-00079-x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Middleton G, Hamanoue M, Enokido Y, Wyatt S, Pennica D, Jaffray E, Hay RT, Davies AM (2000) Cytokine-induced nuclear factor kappa B activation promotes the survival of developing neurons. J Cell Biol 148:325–332</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10648565</ArticleId>
            <ArticleId IdType="pmc">2174280</ArticleId>
            <ArticleId IdType="doi">10.1083/jcb.148.2.325</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miyamoto K, Khosrof S, Bursell SE, Rohan R, Murata T, Clermont AC, Aiello LP, Ogura Y, Adamis AP (1999) Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc Natl Acad Sci USA 96:10836–10841</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10485912</ArticleId>
            <ArticleId IdType="pmc">17969</ArticleId>
            <ArticleId IdType="doi">10.1073/pnas.96.19.10836</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mizutani M, Gerhardinger C, Lorenzi M (1998) Muller cell changes in human diabetic retinopathy. Diabetes 47:445–449</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9519752</ArticleId>
            <ArticleId IdType="doi">10.2337/diabetes.47.3.445</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rashid RR, Fazal A, Khan QU, Qamar MU, Ahmed F, Laique T (2020) Comparison of serum brain-derived neurotrophic factor levels in diabetic patients with and without retinopathy. Cureus 12(12):e12028</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33457130</ArticleId>
            <ArticleId IdType="pmc">7797422</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rodriguez-Tébar A, Barde YA (1988) Binding characteristics of brain-derived neurotrophic factor to its receptors on neurons from the chick embryo. J Neurosci 8(9):3337–3342</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2845018</ArticleId>
            <ArticleId IdType="pmc">6569431</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.08-09-03337.1988</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Romero-Aroca P, Baget-Bernaldiz M, Pareja-Rios A, Lopez-Galvez M, Navarro-Gil R, Verges R (2016) Diabetic macular edema pathophysiology: vasogenic versus inflammatory. J Diabetes Res 2016:2156273</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27761468</ArticleId>
            <ArticleId IdType="pmc">5059543</ArticleId>
            <ArticleId IdType="doi">10.1155/2016/2156273</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rübsam A, Parikh S, Fort PE (2018) Role of inflammation in diabetic retinopathy. Int J Mol Sci 19(4):942</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">5979417</ArticleId>
            <ArticleId IdType="doi">10.3390/ijms19040942</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rungger-Brändle E, Dosso AA, Leuenberger PM (2000) Glial reactivity, an early feature of diabetic retinopathy. Investig Ophthalmol vis Sci 41:1971–1980</Citation>
        </Reference>
        <Reference>
          <Citation>Sorrentino FS, Allkabes M, Salsini G, Bonifazzi C, Perri P (2016) The importance of glial cells in the homeostasis of the retinal microenvironment and their pivotal role in the course of diabetic retinopathy. Life Sci 162:54–59</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27497914</ArticleId>
            <ArticleId IdType="doi">10.1016/j.lfs.2016.08.001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singer MA, Kermany DS, Waters J, Jansen ME, Tyler L (2016) Diabetic macular edema: it is more than just VEGF. F1000 Research 5: F1000 Faculty Rev-1019</Citation>
        </Reference>
        <Reference>
          <Citation>Tang J, Kern TS (2011) Inflammation in diabetic retinopathy. Prog Retin Eye Res 30:343–358</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21635964</ArticleId>
            <ArticleId IdType="pmc">3433044</ArticleId>
            <ArticleId IdType="doi">10.1016/j.preteyeres.2011.05.002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang J, Xueliang Xu, Elliott MH, Zhu M, Le Y-Z (2010) Müller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage. Diabetes 59:2297–2305</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20530741</ArticleId>
            <ArticleId IdType="pmc">2927953</ArticleId>
            <ArticleId IdType="doi">10.2337/db09-1420</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Whitehead M, Wickremasinghe S, Osborne A, Van Wijngaarden P, Martin KR (2018) Diabetic retinopathy: a complex pathophysiology requiring novel therapeutic strategies. Expert Opin Biol Ther 18:1257–1270</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30408422</ArticleId>
            <ArticleId IdType="pmc">6299358</ArticleId>
            <ArticleId IdType="doi">10.1080/14712598.2018.1545836</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu J, Zhong Y, Cheng Y, Shen X, Wang J, Wei Y (2011) Effect of high hydrostatic pressure on the expression of glutamine synthetase in rat retinal Müller cells cultured in vitro. Exp Ther Med 2:513–516</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22977533</ArticleId>
            <ArticleId IdType="pmc">3440778</ArticleId>
            <ArticleId IdType="doi">10.3892/etm.2011.239</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yuuki T, Kanda T, Kimura Y, Kotajima N, Tamura J, Kobayashi I, Kishi S (2001) Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy. J Diabetes Its Complicat 15:257–259</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1056-8727(01)00155-6</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhen YF, Zhang J, Liu XY, Fang H, Tian LB, Zhou DH, Kosten TR, Zhang XY (2013) Low BDNF is associated with cognitive deficits in patients with type 2 diabetes. Psychopharmacology 227:93–100</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23263460</ArticleId>
            <ArticleId IdType="doi">10.1007/s00213-012-2942-3</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
